About Nicholas Saccomano
Nicholas Saccomano is a president and CEO, director at OnKure Therapeutics.
Form D filings name Nicholas Saccomano as a director at OnKure.
Nicholas Saccomano reports to the SEC as a director or officer of 2 public companies, including Array Biopharma (ARRY).
Nicholas Saccomano first appears on SEC filings in 2014.
Experience
This experience comes from SEC filings. The years are when the filings name Nicholas Saccomano in the role, so the role may have started earlier or lasted longer.
OI
OnKure Therapeutics, Inc.
President and CEO, director
2024 – 2026 · Public company (OKUR)
AI
Array Biopharma Inc.
CSO
2014 – 2019 · Public company (ARRY)
Key Colleagues at Startups
The people Nicholas Saccomano works with at each company, as listed on that company's latest Form D.
OnKure, Inc. · Form D, Apr 3, 2023
AP
Anthony Piscopio
Executive officer and director
RC
R. Carruthers
Director
AP
Andrew Phillips
Director
IM
Isaac Manke
Director
DW
Duncan Walker
Executive officer
JW
James Winkler
Executive officer
JL
Jason Leverone
Executive officer
KO
Keith Olivia
Secretary